Fig. 1From: Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetesBetween-group differences (with 95 % confidence interval) in least square (LS) mean percentage changes from baseline at Week 12 in LDL-C, non-HDL-C and apoB for the overall population and patient subgroups defined by baseline triglyceride (TG) value (i.e., < and ≥2.26 mmol/L)Back to article page